Efficacy of VAC therapy for preventing DLI after LVAD implantation.

Not Applicable

• Conditions: Advanced heart failure

• Registration Number: JPRN-jRCTs032180368
• Lead Sponsor: Ono Minoru

Brief Summary

Prophylactic NPWT use at the driveline exit site was safe following LVAD implantation; however, it did not significantly reduce the risk of DLI.

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-03-18
• Study Completion: 2021-10-08
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

1) Patient who undergoes implantation of left ventricular assist device as bridge to transplantation.
2) 16 years old or older.
3) Patient who understands the purpose of this study and consents the entry.
4) Patient who obtained consent from the proxies when the patient does not have sufficient judgment ability or consciousness.

Exclusion Criteria

1) Patients who have uncontrollable infections.
2) Patients who have a tendency to bleed in drive-line wound site.
3) Patients who are difficult to close the wound by vacuum assisted closure device.
4) Patients who have an allergy to foam.
5) Patients researchers have determined to be inappropriate.

Study & Design

• Study Type: Interventional
• Study Design: Not specified